Skip to main content
CellaVision logo

CellaVision — Investor Relations & Filings

Ticker · CEVI ISIN · SE0000683484 LEI · 529900IUBZBZ0HXFJ114 ST Manufacturing
Open in API
Filings indexed 388 across all filing types
Latest filing 2025-04-02 Proxy Solicitation & In…
Country SE Sweden
Listing ST CEVI

About CellaVision

https://www.cellavision.com/

CellaVision is a medical technology company that provides digital solutions for cell morphology in hematology. The company specializes in automating and standardizing the analysis of blood and other body fluids for both human and veterinary applications. Its core offerings include a complete system of analyzers, instruments, software, and reagents designed for hematology laboratories of all sizes. By utilizing patented technology that integrates automated microscopy, advanced image analysis, and artificial intelligence, CellaVision's systems digitize the traditional manual review of blood smears. This automation enhances laboratory workflow efficiency, improves diagnostic accuracy, and facilitates remote collaboration among healthcare professionals, advancing diagnostic certainty.

Recent filings

Filing Released Lang Actions
KALLELSE TILL ÅRSSTÄMMA i CELLAVISION AB (PUBL)
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a formal 'Kallelse till årsstämma' (Notice of Annual General Meeting) for CellaVision AB. It contains the agenda, proposals for board elections, dividend recommendations, and remuneration guidelines for the upcoming AGM. This document is a proxy statement/information circular provided to shareholders to inform them of the meeting and solicit their votes, which fits the definition of a Proxy Solicitation & Information Statement.
2025-04-02 Swedish
NOTICE OF ANNUAL GENERAL MEETING IN CELLAVISION AB (publ)
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a formal 'Notice of Annual General Meeting' for CellaVision AB. It contains the agenda, proposals for board elections, remuneration guidelines, and dividend proposals for the upcoming AGM. This document is designed to inform shareholders of the meeting details and solicit their participation and votes, which aligns perfectly with the definition of a Proxy Solicitation & Information Statement.
2025-04-02 English
Earnings Release 2024
Earnings Release Classification · 1% confidence The document provides detailed financial results for the period '1 oktober – 31 december 2024' (Q4 2024) and the full year ('Jan-dec 2024'). It includes key metrics like Nettoomsättning (Net Sales), EBITDA, EBITDA-marginal, Resultat per aktie (Earnings per share), and cash flow, along with a CEO's statement and segmental analysis. This structure, covering a full fiscal period with comprehensive financial tables and management commentary, strongly indicates a periodic financial report. Since the period covered is a quarter (Q4) and the report is comprehensive (not just a brief highlights release), it fits the definition of an Interim/Quarterly Report (IR). It is too detailed to be just an Earnings Release (ER) and is not the full annual filing (10-K). Q4 2024
2025-02-06 Swedish
Interim / Quarterly Report 2024
Interim / Quarterly Report Classification · 1% confidence The document is titled 'CellaVision Interim Report Q4 Year-end Bulletin 2024'. It contains comprehensive financial statements, including income statements, cash flow data, and regional performance analysis for the fourth quarter and full year 2024. It is a substantive financial report rather than a mere announcement or certification, fitting the definition of an Interim/Quarterly Report. Q4 2024
2025-02-06 English
Major Shareholding Notification 2024
Major Shareholding Notification Classification · 1% confidence The document details a change in shareholding by Swedbank Robur Fonder AB concerning CellaVision AB. Specifically, it outlines the 'Before the transaction' and 'After the transaction' share quantities and voting rights percentages, noting the 'Reason for major shareholding notification' as a 'Sell'. This structure—tracking ownership changes and crossing thresholds—is characteristic of a Major Shareholding Notification. The document explicitly mentions the resulting percentage (4.97424%) falling below a threshold (5%), which aligns perfectly with the definition for Major Shareholding Notification (MRQ). The document length is short (3160 chars), but the content is the notification itself, not an announcement of a report.
2024-11-29 English
Nomination Committee for the CellaVision Annual General Meeting 2025
AGM Information Classification · 1% confidence The document is an announcement regarding the formation of a Nomination Committee for the upcoming 2025 Annual General Meeting. It outlines the committee members, their responsibilities, and instructions for shareholders to submit proposals. It does not contain the full proxy statement or the meeting materials themselves, but rather serves as a preliminary governance announcement related to the AGM process. Given the specific nature of board-related committee appointments and AGM preparation, it fits best under Governance Information (CGR) or as a general regulatory announcement. However, since it specifically details the governance structure for the upcoming AGM, CGR is the most accurate classification.
2024-10-30 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.